Levator resection with suspensory ligament of the superior fornix suspension for correction of pediatric congenital ptosis with poor levator function

Chen, W; Liu, Z; Tian, Qinghua; Niu, Huijun; Liu, F; Wang, Xiaoming; Xiu, Yanghui; Dong, Ning

doi:10.1038/eye.2016.165

Cited by 9 publications

(8 citation statements)

References 15 publications

(11 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This may be due to the long relaxation time of elastic materials used in frontalis suspension leads to unstable results and upper eyelid retraction. In frontalis suspension, excessive movement of the frontalis muscle may induce inflammation, infection, extravasation, extrusion of materials, eyelid deformation, and involuntary paroxysmal movement of eyelids in the upward direction [16]. In comparison, CFS is less invasive and harmful to tissues and blood vessels and does not change the movement direction of the upper eyelid, thereby reducing lid lag.…”

Section: Discussionmentioning

confidence: 99%

Treatment of Severe Ptosis by Conjoint Fascial Sheath Suspension

Sang

Fang

et al. 2021

BioMed Research International

View full text Add to dashboard Cite

Objective. To explore the role of conjoint fascial sheath (CFS) suspension in the treatment of severe ptosis. Methods. A total of 110 patients with severe ptosis who were admitted to our hospital from May 2018 to December 2020 were included. Fifty-seven patients treated with frontalis suspension were assigned into group A, and the remaining 53 patients treated with CFS suspension were assigned into group B. The curative effect, ocular surface alterations, complications, and satisfaction in the two groups were compared. Results. Patients in group B suffered from severe upper eyelid retraction and lid lag than those in group A, as well as more limited range of motion (ROM) ( P < 0.05 ). The curative effect and patient satisfaction in group B were higher than those in group A ( P < 0.05 ). Postsurgical complications in group B were fewer than those in group A ( P < 0.05 ). Conclusion. CFS suspension is effective in the treatment of severe ptosis.

show abstract

Section: Discussionmentioning

confidence: 99%

Treatment of Severe Ptosis by Conjoint Fascial Sheath Suspension

Sang

Fang

et al. 2021

BioMed Research International

View full text Add to dashboard Cite

show abstract

“…In this study, good surgical results were achieved after surgery in both group A and group B. The mean MRD1 of group A at the last visit was 3.00 ± 0.69 mm, which approximates the result of 3.10 ± 0.22 (22). The corrective effect was 77.78% at the last visit in group A, which is better than the result of 67.92% in a previous report (23).…”

Section: Discussionsupporting

confidence: 55%

Modified conjoint fascial sheath suspension for the correction of severe congenital blepharoptosis in pediatric patients at different ages

Wang

Liu²,

Li³

et al. 2022

Front. Pediatr.

View full text Add to dashboard Cite

ObjectiveTo evaluate the surgical outcomes of modified combined fascia sheath (CFS) and levator muscle (LM) complex suspension for the correction of severe congenital blepharoptosis in pediatric patients.MethodsPediatric patients with severe congenital blepharoptosis were enrolled form July 2017 to July 2021. All patients were divided into two groups according to their age (group A ≤ 7 years; group B > 7 years) and received CFS + LM suspension surgery. Main surgical outcome indexes include margin reflex distance 1 (MRD1) and MRD1 regression. Postoperative complications such as lagophthalmos (LAG), conjunctival prolapse, exposure keratopathy and trichiasis were documented.ResultsFifty patients (60 eyes) were enrolled, including 17 patients (18 eyes) in group A and 33 patients (42 eyes) in group B. The MRD1 in group A was 3.06 ± 0.64 mm at 6 months after the operation, and the MRD1 in group B was 2.64 ± 0.69 mm 6 months postoperatively which is significantly lower than that of group A (P = 0. 044). At the last visit, however, the MRD1 in group A was 3.00 ± 0.69 mm and the MRD1 in group B was 2.64 ± 0.70 mm. There was no significant difference in MRD1 between two groups in long term (P = 0.255). Additionally, there were a variety of degrees of MRD1 regression, especially in the first month after the operation in both groups (both P < 0.001). Moreover, there were 9 cases of postoperative complications in group A and 13 cases in group B. The overall occurrence of postoperative complications in group A was significantly lower than that in groups B (χ2 = 4.413, P = 0.036).ConclusionsCFS + LM suspension, a modified CFS-based surgery, is an effective treatment for severe congenital blepharoptosis in pediatric patients. Moreover, CFS + LM suspension demonstrate excellent long-term outcomes, including good movement of the eyelid, satisfied eyelid closure and fewer postoperative complications.

show abstract

“…Frontalis muscle suspension and shortening of levator palpebrae superioris muscle are both common surgical methods for severe ptosis. Direct frontalis muscle suspension is to ameliorate the symptoms of ptosis by lifting the upper eyelid with the strength of frontalis muscle as a supplementary strengthen or replaced strength and indirect frontalis muscle suspension is to connect the frontalis muscle and tarsus through other materials while shortening of levator palpebrae superioris muscle is an operation method for shortening the levator palpebrae superioris muscle [15][16][17] . Frontalis muscle suspension can lift the upper eyelid with the aid of frontalis muscle to increase the power of lifting eyelid and achieve good surgical results.…”

Section: Table 1: Comparison Of Clinical Efficacy Between the Two Groupsmentioning

confidence: 99%

Efficacy of Modified Shortening of Levator Palpebrae Superioris Muscle on Patients with Ptosis

Li¹,

Li²

2021

IJPS

View full text Add to dashboard Cite

To explore the efficacy of modified shortening of levator palpebrae superioris muscle on patients with ptosis. A total of 78 patients with mild or moderate ptosis admitted to our hospital were enrolled and assigned to a control group and an observation group. Patients in the control group were treated with frontalis muscle suspension and those in the observation group were treated with modified shortening of levator palpebrae superioris muscle and the efficacy on ptosis of patients in the two groups was compared. The effective correction rate of the observation group was significantly higher than that of the control group ( 92.59 % vs. 78.72 %) and at 1 st and 7 th d after operation, compared with the control group, the observation group experienced significantly more blinking times and significantly less eyelid closure insufficiency. After operation, the two groups suffered from complications including interbrow hematoma, symblepharon, eyelid entropion, ectropion or angulation, poor upper eyelid radian, exposure keratitis and the incidence of complications in the observation group was not significantly different from that in the control group. In addition, during the follow-up period, the upper eyelid retraction of the observation group was significantly less than that of the control group (all p<0.05). The modified shortening of levator palpebrae superioris muscle can provide reliable efficacy for patients with ptosis and it results in less complications and smaller upper eyelid retraction.

show abstract

Levator resection with suspensory ligament of the superior fornix suspension for correction of pediatric congenital ptosis with poor levator function

Cited by 9 publications

References 15 publications

Treatment of Severe Ptosis by Conjoint Fascial Sheath Suspension

Treatment of Severe Ptosis by Conjoint Fascial Sheath Suspension

Modified conjoint fascial sheath suspension for the correction of severe congenital blepharoptosis in pediatric patients at different ages

Efficacy of Modified Shortening of Levator Palpebrae Superioris Muscle on Patients with Ptosis

Contact Info

Product

Resources

About